## Abstract Peripheral blood lymphocytes from 61 melanoma patients were tested by a microcytotoxicity test for cell‐mediated immunity against melanoma cells. Lymphocytes from 13/25 patients were cytotoxic for autologous tumour cells, while lymphocytes from 31/56 patients were cytotoxic in the allog
Tumour-associated lymphocyte cytotoxicity superimposed on “Spontaneous” cytotoxicity in melanoma patients
✍ Scribed by Jan E. De Vries; Philip Rümke
- Publisher
- John Wiley and Sons
- Year
- 1976
- Tongue
- French
- Weight
- 674 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Lymphocytes from 16 stage 1, 6 stage II and 31 stage III melanoma patients (MP) and 51 healthy donors (HD) were tested as far as possible in parallel on a melanoma cell line (NK1‐4), a bladder carcinoma cell line (T 24) and 18 different short‐term melanoma cultures. Lymphocytes from MP and HD showed cytotoxic effects towards all three types of target cells. Lymphocytes from HD showed the strongest “spontaneous” cytotoxic effects on NKI‐4 cells whereas, in general, weak cytotoxic effects were seen on short‐term cultured melanoma cells. Within the different lymphocyte donor groups an enormous variation in cytotoxic effects was observed. However, the overall cytotoxic effects of stage I and II MP were significantly higher than those of the HD‐group. Stage I MP showed significantly stronger cytotoxic effects on NKI‐4 cells than on T 24 cells, indicating that tumour‐associated lymphocyte cytotoxicity was superimposed on spontaneous cytotoxicity.
📜 SIMILAR VOLUMES
## Abstract Lymphocytes from 25 healthy donors were separated into T‐ and non‐T‐fractions by means of E and EAC rosette‐formation. The unfractionated lymphocyte population was tested simultaneously with E and non‐EAC rosette‐forming cells (T‐cells) and EAC and non‐E rosette‐forming cells (non‐T cel
Of 27 patients with granular lymphocyte-proliferative disorders (GLPD), 18 patients had CD3' T-cell-lineage GLPD (T-GLPD), and 9 patients had CD3-CD16' natural killer (NK) cell-lineage GLPD (NK-GLPD). In 9 of the 18 patients with T-GLPD, severe anemia of ~7 . 5 g/dl hemoglobin (mean 5.4 g/dl) and er